Amiodarone

Amiodarone is used to treat and prevent certain types of serious, life-threatening ventricular arrhythmias (a certain type of abnormal heart rhythm when other medications did not help or could not be tolerated. Amiodarone is in a class of medications called antiarrhythmics. It works by relaxing overactive heart muscles.

Amiodarone comes as a tablet to take by mouth. It is usually taken once or twice a day. You may take amiodarone either with or without food, but be sure to take it the same way each time.Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take amiodarone exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Amiodarone is also sometimes used to treat other types of arrhythmias. Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking amiodarone,

• tell your doctor and pharmacist if you are allergic to amiodarone, iodine, any other medications, or any of the ingredients in amiodarone tablets. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

• tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, and nutritional supplements you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: antidepressants ('mood elevators') such as trazodone (Oleptro); anticoagulants ('blood thinners') such as dabigatran (Pradaxa) and warfarin (Coumadin, Jantoven); certain cholesterol lowering medications such as atorvastatin (Lipitor, in Caduet, in Liptruzet), cholestyramine (Prevalite), lovastatin (Altoprev, in Advicor), and simvastatin (Zocor, in Simcor, in Vytorin); cimetidine; clopidogrel (Plavix); cyclosporine (Gengraf, Neoral, Sandimmune); dextromethorphan (a medication in many cough preparations); fentanyl (Actiq, Duragesic, Fentora, others); HIV protease inhibitors such as indinavir (Crixivan) and ritonavir (Norvir, in Kaletra, in Viekira Pak); ledipasvir and sofosbuvir (Harvoni); lithium (Lithobid); loratadine (Claritin); medications for diabetes or seizures; methotrexate (Otrexup, Rasuvo, Trexall); narcotic medications for pain; rifampin (Rifadin, Rimactane, in Rifamate, in Rifater); and sofosbuvir (Solvaldi) with simeprevir (Olysio). Many other medications may interact with amiodarone, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list. Your doctor may have to change the doses of your medications or monitor you carefully for side effects.

• tell your doctor what herbal products you are taking, especially St. John's wort.

• tell your doctor if you have diarrhea or have or have ever had any of the conditions mentioned in the IMPORTANT WARNING section or problems with your blood pressure.

• tell your doctor if you are pregnant or plan to become pregnant. Talk to your doctor if you plan to become pregnant during your treatment because amiodarone may remain in your body for some time after you stop taking it. If you become pregnant while taking amiodarone, call your doctor immediately. Amiodarone can cause fetal harm.

• tell your doctor if you are breastfeeding. Do not breastfeed while you are taking amiodarone.

• talk to your doctor about the risks of taking this medication if you are 65 years of age or older. Older adults should not usually take amiodarone because it is not as safe or effective as other medication(s) that can be used to treat the same condition.

• if you are having surgery, including dental surgery or laser eye surgery, tell your doctor or dentist that you are taking amiodarone.

• plan to avoid unnecessary or prolonged exposure to sunlight or sunlamps and to wear protective clothing, sunglasses, and sunscreen. Amiodarone may make your skin sensitive to sunlight. Exposed skin may turn blue-gray and may not return to normal even after you stop taking this medication.

• you should know that amiodarone may cause vision problems including permanent blindness. Be sure to have regular eye exams during your treatment and call your doctor if your eyes become dry, sensitive to light, if you see halos, or have blurred vision or any other problems with your vision.

• you should know that amiodarone may remain in your body for several months after you stop taking it. You may continue to experience side effects of amiodarone during this time. Be sure to tell every health care provider who treats you or prescribes any medication for you during this time that you have recently stopped taking amiodarone.

Do not drink grapefruit juice while you are taking this medication.

Skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

• Amiodarone may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • constipation

  • loss of appetite

  • headache

  • decreased sex drive

  • difficulty falling asleep or staying asleep

  • flushing

  • changes in ability to taste and smell

  • changes in amount of saliva

• Some side effects can be serious. If you experience any of the following symptoms, or those listed in the IMPORTANT WARNING section, call your doctor immediately or get emergency medical treatment:

  • rash

  • weight loss or gain

  • restlessness

  • weakness

  • nervousness

  • irritability

  • intolerance to heat or cold

  • thinning hair

  • excessive sweating

  • changes in menstrual cycle

  • swelling in the front of the neck (goiter)

  • swelling of the hands, feet, ankles, or lower legs

  • uncontrollable shaking of a part of the body

  • decreased concentration

  • movements that you cannot control

  • poor coordination or trouble walking

  • numbness or tingling in the hands, legs, and feet

  • muscle weakness

• Amiodarone may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

• If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from light, excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

• slow heartbeat

• nausea

• blurred vision

• lightheadedness

• fainting

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug	Interaction
Moxifloxacin	Moxifloxacin The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Amiodarone.
Repaglinide	Repaglinide The metabolism of Amiodarone can be decreased when combined with Repaglinide.
Montelukast	Montelukast The metabolism of Amiodarone can be decreased when combined with Montelukast.
Insulin Glargine (rDNA origin) Injection	Insulin Glargine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin glargine.
Leflunomide	Leflunomide The metabolism of Leflunomide can be decreased when combined with Amiodarone.
Delavirdine	Delavirdine The metabolism of Amiodarone can be decreased when combined with Delavirdine.
Nevirapine	Nevirapine The metabolism of Nevirapine can be decreased when combined with Amiodarone.
Atorvastatin	Atorvastatin The serum concentration of Atorvastatin can be increased when it is combined with Amiodarone.
Dolasetron	Dolasetron The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Dolasetron.
Alendronate	Alendronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Amiodarone.
Aminophylline	Aminophylline The metabolism of Aminophylline can be decreased when combined with Amiodarone.
Anagrelide	Anagrelide The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Amiodarone.
Bisacodyl	Bisacodyl The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Amiodarone.
Candesartan	Candesartan The metabolism of Amiodarone can be decreased when combined with Candesartan.
Cilostazol	Cilostazol The metabolism of Cilostazol can be decreased when combined with Amiodarone.
Clopidogrel	Clopidogrel The risk or severity of bleeding can be increased when Amiodarone is combined with Clopidogrel.
Erythromycin and Sulfisoxazole	Erythromycin and Sulfisoxazole The metabolism of Amiodarone can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives)	Estrogen and Progestin (Oral Contraceptives) The metabolism of Amiodarone can be decreased when combined with Conjugated estrogens.
Fenofibrate	Fenofibrate The metabolism of Amiodarone can be decreased when combined with Fenofibrate.
Guanfacine	Guanfacine The risk or severity of adverse effects can be increased when Amiodarone is combined with Guanfacine.
Magnesium Gluconate	Magnesium Gluconate The risk or severity of hypotension can be increased when Amiodarone is combined with Magnesium gluconate.
Magnesium Hydroxide	Magnesium Hydroxide The risk or severity of hypotension can be increased when Amiodarone is combined with Magnesium hydroxide.
Magnesium Oxide	Magnesium Oxide The risk or severity of hypotension can be increased when Amiodarone is combined with Magnesium oxide.
Methylergonovine	Methylergonovine The metabolism of Amiodarone can be decreased when combined with Methylergometrine.
Miglitol	Miglitol The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Miglitol.
Nafarelin	Nafarelin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Amiodarone.
Olsalazine	Olsalazine The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Olsalazine.
Paregoric	Paregoric The metabolism of Amiodarone can be decreased when combined with Morphine.
Penbutolol	Penbutolol The therapeutic efficacy of Acebutolol can be increased when used in combination with Amiodarone.
Polyethylene glycol-electrolyte solution (PEG-ES)	Polyethylene glycol-electrolyte solution (PEG-ES) The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Amiodarone.
Potassium	Potassium Potassium may increase the hyperkalemic activities of Amiodarone.
Psyllium	Psyllium The therapeutic efficacy of Plantago seed can be decreased when used in combination with Amiodarone.
Ranitidine	Ranitidine The metabolism of Ranitidine can be decreased when combined with Amiodarone.
Reserpine	Reserpine The serum concentration of Amiodarone can be increased when it is combined with Reserpine.
Tacrolimus	Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Amiodarone.
Tizanidine	Tizanidine The metabolism of Amiodarone can be decreased when combined with Tizanidine.
Triamcinolone	Triamcinolone The metabolism of Amiodarone can be increased when combined with Triamcinolone.
Zolmitriptan	Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Amiodarone.
Doxycycline Injection	Doxycycline Injection The metabolism of Amiodarone can be decreased when combined with Doxycycline.
Famotidine Injection	Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Amiodarone.
Fluconazole Injection	Fluconazole Injection The metabolism of Amiodarone can be decreased when combined with Fluconazole.
Foscarnet Injection	Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Amiodarone.
Hydromorphone Injection	Hydromorphone Injection The metabolism of Hydromorphone can be decreased when combined with Amiodarone.
Levofloxacin Injection	Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Amiodarone.
Meperidine Injection	Meperidine Injection The metabolism of Amiodarone can be increased when combined with Meperidine.
Methylprednisolone Injection	Methylprednisolone Injection The metabolism of Amiodarone can be increased when combined with Methylprednisolone.
Metoclopramide Injection	Metoclopramide Injection The metabolism of Metoclopramide can be decreased when combined with Amiodarone.
Metronidazole Injection	Metronidazole Injection The metabolism of Amiodarone can be decreased when combined with Metronidazole.
Morphine Injection	Morphine Injection The metabolism of Amiodarone can be decreased when combined with Morphine.
Pamidronate Injection	Pamidronate Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Amiodarone.
Zidovudine Injection	Zidovudine Injection The metabolism of Amiodarone can be decreased when combined with Zidovudine.
Altretamine	Altretamine Amiodarone may increase the orthostatic hypotensive activities of Amphetamine.
Cyclosporine	Cyclosporine The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.
Ondansetron	Ondansetron The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Ondansetron.
Enoxaparin Injection	Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Enoxaparin.
Granisetron	Granisetron The risk or severity of QTc prolongation can be increased when Granisetron is combined with Amiodarone.
Torsemide	Torsemide The metabolism of Amiodarone can be decreased when combined with Torasemide.
Olanzapine	Olanzapine The metabolism of Olanzapine can be decreased when combined with Amiodarone.
Alosetron	Alosetron The metabolism of Alosetron can be decreased when combined with Amiodarone.
Dofetilide	Dofetilide The risk or severity of adverse effects can be increased when Dofetilide is combined with Amiodarone.
Eprosartan	Eprosartan The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Amiodarone.
Hydroxychloroquine	Hydroxychloroquine The metabolism of Amiodarone can be decreased when combined with Hydroxychloroquine.
Meloxicam	Meloxicam The metabolism of Amiodarone can be decreased when combined with Meloxicam.
Orlistat	Orlistat Orlistat can cause a decrease in the absorption of Amiodarone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxcarbazepine	Oxcarbazepine The metabolism of Amiodarone can be increased when combined with Oxcarbazepine.
Risedronate	Risedronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Amiodarone.
Sevelamer	Sevelamer The excretion of Amiodarone can be increased when combined with Sevelamer.
Telmisartan	Telmisartan The risk or severity of adverse effects can be increased when Amiodarone is combined with Telmisartan.
Anakinra	Anakinra The metabolism of Amiodarone can be increased when combined with Anakinra.
Desloratadine	Desloratadine The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Amiodarone.
Linezolid	Linezolid Linezolid may increase the orthostatic hypotensive activities of Amiodarone.
Rivastigmine	Rivastigmine Rivastigmine may increase the bradycardic activities of Amiodarone.
Trimipramine	Trimipramine The serum concentration of Trimipramine can be increased when it is combined with Amiodarone.
Etanercept Injection	Etanercept Injection The metabolism of Amiodarone can be increased when combined with Etanercept.
Modafinil	Modafinil The metabolism of Amiodarone can be increased when combined with Modafinil.
Perindopril	Perindopril The risk or severity of hyperkalemia can be increased when Perindopril is combined with Amiodarone.
Tenofovir	Tenofovir The metabolism of Amiodarone can be decreased when combined with Tenofovir.
Choline Magnesium Trisalicylate	Choline Magnesium Trisalicylate The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Choline magnesium trisalicylate.
Sirolimus	Sirolimus Amiodarone may increase the immunosuppressive activities of Sirolimus.
Epinephrine Injection	Epinephrine Injection The metabolism of Amiodarone can be decreased when combined with Epinephrine.
Eplerenone	Eplerenone The risk or severity of adverse effects can be increased when Amiodarone is combined with Eplerenone.
Escitalopram	Escitalopram The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Escitalopram.
Olmesartan	Olmesartan The risk or severity of adverse effects can be increased when Amiodarone is combined with Olmesartan.
Zonisamide	Zonisamide The risk or severity of adverse effects can be increased when Zonisamide is combined with Amiodarone.
Adalimumab Injection	Adalimumab Injection The metabolism of Amiodarone can be increased when combined with Adalimumab.
Aripiprazole	Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Amiodarone.
Atomoxetine	Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Amiodarone.
Atazanavir	Atazanavir The serum concentration of Amiodarone can be increased when it is combined with Atazanavir.
Almotriptan	Almotriptan The metabolism of Amiodarone can be decreased when combined with Almotriptan.
Eletriptan	Eletriptan The metabolism of Eletriptan can be decreased when combined with Amiodarone.
Mefloquine	Mefloquine The metabolism of Amiodarone can be decreased when combined with Mefloquine.
Polyethylene Glycol 3350	Polyethylene Glycol 3350 The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Amiodarone.
Rosuvastatin	Rosuvastatin The metabolism of Rosuvastatin can be increased when combined with Amiodarone.
Vardenafil	Vardenafil The metabolism of Vardenafil can be decreased when combined with Amiodarone.
Alfuzosin	Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Amiodarone.
Aprepitant	Aprepitant The metabolism of Amiodarone can be decreased when combined with Aprepitant.
Memantine	Memantine The serum concentration of Memantine can be increased when it is combined with Amiodarone.
Tegaserod	Tegaserod The metabolism of Tegaserod can be decreased when combined with Amiodarone.
Tadalafil	Tadalafil Amiodarone may increase the hypotensive activities of Tadalafil.
Fosamprenavir	Fosamprenavir The serum concentration of Amiodarone can be increased when it is combined with Fosamprenavir.
Frovatriptan	Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Amiodarone.
Gemifloxacin	Gemifloxacin The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Amiodarone.
Progesterone	Progesterone The metabolism of Amiodarone can be increased when combined with Progesterone.
Apomorphine Injection	Apomorphine Injection The metabolism of Amiodarone can be decreased when combined with Apomorphine.
Infliximab Injection	Infliximab Injection The metabolism of Amiodarone can be increased when combined with Infliximab.
Protriptyline	Protriptyline The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Protriptyline.
Rifaximin	Rifaximin The serum concentration of Rifaximin can be increased when it is combined with Amiodarone.
Duloxetine	Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Amiodarone is combined with Duloxetine.
Norethindrone	Norethindrone The metabolism of Amiodarone can be decreased when combined with Norethisterone.
Bosentan	Bosentan The metabolism of Amiodarone can be increased when combined with Bosentan.
Cinacalcet	Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Amiodarone.
Erlotinib	Erlotinib The metabolism of Amiodarone can be decreased when combined with Erlotinib.
Eszopiclone	Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Amiodarone.
Ganciclovir	Ganciclovir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Amiodarone.
Insulin Aspart (rDNA Origin) Injection	Insulin Aspart (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin aspart.
Solifenacin	Solifenacin The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Solifenacin.
Voriconazole	Voriconazole The metabolism of Amiodarone can be decreased when combined with Voriconazole.
Dextroamphetamine	Dextroamphetamine Amiodarone may increase the orthostatic hypotensive activities of Amphetamine.
Entecavir	Entecavir The metabolism of Entecavir can be decreased when combined with Amiodarone.
Pramlintide Injection	Pramlintide Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Pramlintide.
Exenatide Injection	Exenatide Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Exenatide.
Ibandronate	Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Amiodarone.
Isocarboxazid	Isocarboxazid Isocarboxazid may increase the orthostatic hypotensive activities of Amiodarone.
Ramelteon	Ramelteon The metabolism of Ramelteon can be decreased when combined with Amiodarone.
Darifenacin	Darifenacin The metabolism of Darifenacin can be decreased when combined with Amiodarone.
Fentanyl	Fentanyl The risk or severity of adverse effects can be increased when Amiodarone is combined with Fentanyl.
Pregabalin	Pregabalin The risk or severity of adverse effects can be increased when Pregabalin is combined with Amiodarone.
Deferasirox	Deferasirox The metabolism of Amiodarone can be decreased when combined with Deferasirox.
Phenylephrine	Phenylephrine The risk or severity of hypertension can be decreased when Phenylephrine is combined with Amiodarone.
Tipranavir	Tipranavir The metabolism of Amiodarone can be decreased when combined with Tipranavir.
Felbamate	Felbamate The metabolism of Amiodarone can be increased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection	Insulin Detemir (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin detemir.
Ranolazine	Ranolazine The serum concentration of Amiodarone can be increased when it is combined with Ranolazine.
Abatacept Injection	Abatacept Injection The metabolism of Amiodarone can be increased when combined with Abatacept.
Rasagiline	Rasagiline Rasagiline may increase the orthostatic hypotensive activities of Amiodarone.
Imatinib	Imatinib The metabolism of Amiodarone can be decreased when combined with Imatinib.
Sitagliptin	Sitagliptin The metabolism of Amiodarone can be decreased when combined with Sitagliptin.
Varenicline	Varenicline The excretion of Varenicline can be decreased when combined with Amiodarone.
Gefitinib	Gefitinib The metabolism of Amiodarone can be decreased when combined with Gefitinib.
Albuterol	Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Amiodarone.
Paliperidone	Paliperidone The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Paliperidone.
Bortezomib	Bortezomib The serum concentration of Bortezomib can be increased when it is combined with Amiodarone.
Clofarabine Injection	Clofarabine Injection The serum concentration of Amiodarone can be increased when it is combined with Clofarabine.
Insulin Glulisine (rDNA origin) Injection	Insulin Glulisine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin glulisine.
Lubiprostone	Lubiprostone The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Amiodarone.
Oxaliplatin Injection	Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Amiodarone.
Posaconazole	Posaconazole The metabolism of Amiodarone can be decreased when combined with Posaconazole.
Primaquine	Primaquine The metabolism of Amiodarone can be decreased when combined with Primaquine.
Aliskiren	Aliskiren The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Aliskiren.
Darunavir	Darunavir The serum concentration of Amiodarone can be increased when it is combined with Darunavir.
Pemetrexed Injection	Pemetrexed Injection The metabolism of Pemetrexed can be decreased when combined with Amiodarone.
Dimenhydrinate	Dimenhydrinate The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Amiodarone.
Lisdexamfetamine	Lisdexamfetamine The metabolism of Lisdexamfetamine can be decreased when combined with Amiodarone.
Nabilone	Nabilone The metabolism of Amiodarone can be decreased when combined with Nabilone.
Retapamulin	Retapamulin The metabolism of Retapamulin can be decreased when combined with Amiodarone.
Vorinostat	Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Amiodarone.
Sorafenib	Sorafenib The metabolism of Amiodarone can be decreased when combined with Sorafenib.
Sunitinib	Sunitinib The metabolism of Amiodarone can be decreased when combined with Sunitinib.
Dronabinol	Dronabinol The metabolism of Dronabinol can be decreased when combined with Amiodarone.
Lapatinib	Lapatinib The metabolism of Amiodarone can be decreased when combined with Lapatinib.
Levocetirizine	Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Amiodarone.
Dasatinib	Dasatinib The metabolism of Dasatinib can be decreased when combined with Amiodarone.
Mexiletine	Mexiletine The risk or severity of adverse effects can be increased when Amiodarone is combined with Mexiletine.
Armodafinil	Armodafinil The metabolism of Amiodarone can be increased when combined with Armodafinil.
Ivermectin	Ivermectin The metabolism of Amiodarone can be increased when combined with Ivermectin.
Paclitaxel (with polyoxyethylated castor oil) Injection	Paclitaxel (with polyoxyethylated castor oil) Injection The therapeutic efficacy of Castor oil can be decreased when used in combination with Amiodarone.
Temsirolimus	Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Amiodarone.
Nilotinib	Nilotinib The metabolism of Amiodarone can be decreased when combined with Nilotinib.
Toremifene	Toremifene The risk or severity of QTc prolongation can be increased when Toremifene is combined with Amiodarone.
Raltegravir	Raltegravir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Raltegravir.
Bexarotene	Bexarotene The metabolism of Amiodarone can be increased when combined with Bexarotene.
Budesonide	Budesonide The metabolism of Amiodarone can be increased when combined with Budesonide.
Chloramphenicol Injection	Chloramphenicol Injection The metabolism of Amiodarone can be decreased when combined with Chloramphenicol.
Etravirine	Etravirine The metabolism of Amiodarone can be increased when combined with Etravirine.
Arsenic Trioxide Injection	Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Arsenic trioxide.
Mitoxantrone Injection	Mitoxantrone Injection The metabolism of Mitoxantrone can be decreased when combined with Amiodarone.
Desvenlafaxine	Desvenlafaxine The metabolism of Amiodarone can be decreased when combined with Desvenlafaxine.
Cevimeline	Cevimeline The metabolism of Cevimeline can be decreased when combined with Amiodarone.
Nebivolol	Nebivolol The therapeutic efficacy of Nebivolol can be increased when used in combination with Amiodarone.
Tretinoin	Tretinoin The metabolism of Amiodarone can be decreased when combined with Tretinoin.
Bendamustine Injection	Bendamustine Injection The serum concentration of Bendamustine can be increased when it is combined with Amiodarone.
Pilocarpine	Pilocarpine The metabolism of Amiodarone can be decreased when combined with Pilocarpine.
Flecainide	Flecainide The metabolism of Flecainide can be decreased when combined with Amiodarone.
Certolizumab Injection	Certolizumab Injection The metabolism of Amiodarone can be increased when combined with Certolizumab pegol.
Ixabepilone Injection	Ixabepilone Injection The metabolism of Amiodarone can be decreased when combined with Ixabepilone.
Irinotecan Injection	Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Amiodarone.
Daptomycin Injection	Daptomycin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Amiodarone.
Praziquantel	Praziquantel The metabolism of Praziquantel can be decreased when combined with Amiodarone.
Mitotane	Mitotane The metabolism of Amiodarone can be increased when combined with Mitotane.
Rufinamide	Rufinamide The metabolism of Amiodarone can be increased when combined with Rufinamide.
Silodosin	Silodosin The serum concentration of Silodosin can be increased when it is combined with Amiodarone.
Midazolam	Midazolam The serum concentration of Midazolam can be increased when it is combined with Amiodarone.
Naltrexone Injection	Naltrexone Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Amiodarone.
Eltrombopag	Eltrombopag The metabolism of Amiodarone can be decreased when combined with Eltrombopag.
Milnacipran	Milnacipran The metabolism of Amiodarone can be decreased when combined with Milnacipran.
Sodium Phosphate	Sodium Phosphate Amiodarone may increase the hyperkalemic activities of Sodium phosphate, monobasic.
Fesoterodine	Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Amiodarone.
Degarelix Injection	Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Amiodarone.
Betaxolol	Betaxolol The therapeutic efficacy of Betaxolol can be increased when used in combination with Amiodarone.
Iloperidone	Iloperidone The metabolism of Iloperidone can be decreased when combined with Amiodarone.
Prasugrel	Prasugrel The metabolism of Prasugrel can be decreased when combined with Amiodarone.
Lacosamide	Lacosamide The metabolism of Amiodarone can be decreased when combined with Lacosamide.
Everolimus	Everolimus The serum concentration of Everolimus can be increased when it is combined with Amiodarone.
Tolvaptan (low blood sodium)	Tolvaptan (low blood sodium) The serum concentration of Tolvaptan can be increased when it is combined with Amiodarone.
Dronedarone	Dronedarone Amiodarone may increase the QTc-prolonging activities of Dronedarone.
Palonosetron Injection	Palonosetron Injection The metabolism of Palonosetron can be decreased when combined with Amiodarone.
Saxagliptin	Saxagliptin The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Saxagliptin.
Telavancin Injection	Telavancin Injection The risk or severity of QTc prolongation can be increased when Telavancin is combined with Amiodarone.
Romidepsin Injection	Romidepsin Injection The serum concentration of Amiodarone can be increased when it is combined with Romidepsin.
Tapentadol	Tapentadol The metabolism of Tapentadol can be decreased when combined with Amiodarone.
Topotecan	Topotecan The serum concentration of Topotecan can be increased when it is combined with Amiodarone.
Golimumab Injection	Golimumab Injection The metabolism of Amiodarone can be increased when combined with Golimumab.
Pazopanib	Pazopanib The serum concentration of Pazopanib can be increased when it is combined with Amiodarone.
Asenapine	Asenapine The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Asenapine.
Pitavastatin	Pitavastatin The metabolism of Pitavastatin can be increased when combined with Amiodarone.
Albendazole	Albendazole The metabolism of Amiodarone can be decreased when combined with Albendazole.
Oxymorphone	Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Amiodarone.
Liraglutide Injection	Liraglutide Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Liraglutide.
Tocilizumab Injection	Tocilizumab Injection The metabolism of Amiodarone can be increased when combined with Tocilizumab.
Dalfampridine	Dalfampridine The serum concentration of Dalfampridine can be increased when it is combined with Amiodarone.
Fingolimod	Fingolimod Fingolimod may increase the arrhythmogenic activities of Amiodarone.
Eribulin Injection	Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Amiodarone.
Cabazitaxel Injection	Cabazitaxel Injection The metabolism of Amiodarone can be decreased when combined with Cabazitaxel.
Lurasidone	Lurasidone The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Amiodarone.
Acetaminophen Injection	Acetaminophen Injection The metabolism of Amiodarone can be increased when combined with Acetaminophen.
Vilazodone	Vilazodone The metabolism of Vilazodone can be decreased when combined with Amiodarone.
Denileukin Diftitox Injection	Denileukin Diftitox Injection The metabolism of Amiodarone can be decreased when combined with Aldesleukin.
Terbutaline Injection	Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Amiodarone.
Azilsartan	Azilsartan The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Azilsartan medoxomil.
Busulfan Injection	Busulfan Injection The metabolism of Amiodarone can be decreased when combined with Busulfan.
Roflumilast	Roflumilast The metabolism of Amiodarone can be decreased when combined with Roflumilast.
Linagliptin	Linagliptin The metabolism of Amiodarone can be decreased when combined with Linagliptin.
Rilpivirine	Rilpivirine The metabolism of Amiodarone can be decreased when combined with Rilpivirine.
Telaprevir	Telaprevir The metabolism of Glecaprevir can be decreased when combined with Amiodarone.
Potassium Iodide	Potassium Iodide The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Amiodarone.
Cyclophosphamide Injection	Cyclophosphamide Injection The risk or severity of pulmonary toxicity can be increased when Cyclophosphamide is combined with Amiodarone.
Abiraterone	Abiraterone The metabolism of Amiodarone can be decreased when combined with Abiraterone.
Triptorelin Injection	Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Amiodarone.
Rivaroxaban	Rivaroxaban The serum concentration of Rivaroxaban can be increased when it is combined with Amiodarone.
Ticagrelor	Ticagrelor The metabolism of Ticagrelor can be decreased when combined with Amiodarone.
Brentuximab Vedotin Injection	Brentuximab Vedotin Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Amiodarone.
Ruxolitinib	Ruxolitinib Ruxolitinib may increase the bradycardic activities of Amiodarone.
Vandetanib	Vandetanib The metabolism of Vandetanib can be decreased when combined with Amiodarone.
Clobazam	Clobazam The metabolism of Clobazam can be increased when combined with Amiodarone.
Vemurafenib	Vemurafenib The metabolism of Vemurafenib can be decreased when combined with Amiodarone.
Vismodegib	Vismodegib The metabolism of Amiodarone can be decreased when combined with Vismodegib.
Ivacaftor	Ivacaftor The metabolism of Amiodarone can be decreased when combined with Ivacaftor.
Axitinib	Axitinib The metabolism of Amiodarone can be decreased when combined with Axitinib.
Crizotinib	Crizotinib The metabolism of Amiodarone can be decreased when combined with Crizotinib.
Cabergoline	Cabergoline The metabolism of Amiodarone can be decreased when combined with Cabergoline.
Naloxone Injection	Naloxone Injection The metabolism of Amiodarone can be decreased when combined with Naloxone.
Ambrisentan	Ambrisentan The serum concentration of Amiodarone can be increased when it is combined with Ambrisentan.
Carfilzomib Injection	Carfilzomib Injection The serum concentration of Carfilzomib can be increased when it is combined with Amiodarone.
Iloprost	Iloprost The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Iloprost is combined with Amiodarone.
Enzalutamide	Enzalutamide The metabolism of Amiodarone can be increased when combined with Enzalutamide.
Mirabegron	Mirabegron The serum concentration of Mirabegron can be increased when it is combined with Amiodarone.
Regorafenib	Regorafenib The metabolism of Amiodarone can be decreased when combined with Regorafenib.
Bosutinib	Bosutinib The serum concentration of Bosutinib can be increased when it is combined with Amiodarone.
Corticotropin, Repository Injection	Corticotropin, Repository Injection The metabolism of Amiodarone can be increased when combined with Corticotropin.
Linaclotide	Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Amiodarone.
Teriflunomide	Teriflunomide The metabolism of Amiodarone can be decreased when combined with Teriflunomide.
Lorcaserin	Lorcaserin The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Mecasermin.
Cabozantinib (thyroid cancer)	Cabozantinib (thyroid cancer) The metabolism of Amiodarone can be decreased when combined with Cabozantinib.
Bedaquiline	Bedaquiline The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Amiodarone.
Mipomersen Injection	Mipomersen Injection Amiodarone may increase the hepatotoxic activities of Mipomersen.
Tofacitinib	Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Amiodarone.
Alogliptin	Alogliptin The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Alogliptin.
Ponatinib	Ponatinib The metabolism of Amiodarone can be decreased when combined with Ponatinib.
Pomalidomide	Pomalidomide The serum concentration of Amiodarone can be increased when it is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection	Ado-trastuzumab Emtansine Injection The metabolism of Amiodarone can be decreased when combined with Trastuzumab emtansine.
Apixaban	Apixaban The metabolism of Amiodarone can be decreased when combined with Apixaban.
Canagliflozin	Canagliflozin The serum concentration of Amiodarone can be increased when it is combined with Canagliflozin.
Methazolamide	Methazolamide The risk or severity of adverse effects can be increased when Methazolamide is combined with Amiodarone.
Dabrafenib	Dabrafenib The metabolism of Amiodarone can be increased when combined with Dabrafenib.
Ospemifene	Ospemifene The metabolism of Ospemifene can be decreased when combined with Amiodarone.
Trametinib	Trametinib The metabolism of Amiodarone can be increased when combined with Trametinib.
Dolutegravir	Dolutegravir The serum concentration of Dolutegravir can be increased when it is combined with Amiodarone.
Afatinib	Afatinib The serum concentration of Afatinib can be increased when it is combined with Amiodarone.
Levomilnacipran	Levomilnacipran The metabolism of Amiodarone can be decreased when combined with Levomilnacipran.
Vortioxetine	Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Amiodarone.
Perampanel	Perampanel The metabolism of Amiodarone can be increased when combined with Perampanel.
Ibrutinib	Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Amiodarone.
Lomitapide	Lomitapide The metabolism of Amiodarone can be decreased when combined with Lomitapide.
Avanafil	Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Amiodarone.
Ketorolac Injection	Ketorolac Injection The metabolism of Amiodarone can be decreased when combined with Ketorolac.
Obinutuzumab Injection	Obinutuzumab Injection The risk or severity of adverse effects can be increased when Amiodarone is combined with Obinutuzumab.
Simeprevir	Simeprevir The metabolism of Amiodarone can be decreased when combined with Simeprevir.
Sofosbuvir	Sofosbuvir Sofosbuvir may increase the bradycardic activities of Amiodarone.
Dapagliflozin	Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Amiodarone.
Apremilast	Apremilast The metabolism of Amiodarone can be increased when combined with Apremilast.
Ceritinib	Ceritinib Amiodarone may increase the bradycardic activities of Ceritinib.
Siltuximab Injection	Siltuximab Injection The metabolism of Amiodarone can be increased when combined with Siltuximab.
Albiglutide Injection	Albiglutide Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Albiglutide.
Eslicarbazepine	Eslicarbazepine The metabolism of Amiodarone can be increased when combined with Eslicarbazepine.
Belinostat Injection	Belinostat Injection The serum concentration of Belinostat can be increased when it is combined with Amiodarone.
Idelalisib	Idelalisib The metabolism of Idelalisib can be decreased when combined with Amiodarone.
Testosterone Injection	Testosterone Injection The metabolism of Amiodarone can be increased when combined with Testosterone.
Oritavancin Injection	Oritavancin Injection The metabolism of Amiodarone can be increased when combined with Oritavancin.
Empagliflozin	Empagliflozin The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Empagliflozin.
Vorapaxar	Vorapaxar The metabolism of Amiodarone can be decreased when combined with Vorapaxar.
Hydrocodone	Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Amiodarone.
Suvorexant	Suvorexant The metabolism of Amiodarone can be decreased when combined with Suvorexant.
Dulaglutide Injection	Dulaglutide Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Dulaglutide.
Edoxaban	Edoxaban The serum concentration of Edoxaban can be increased when it is combined with Amiodarone.
Olaparib	Olaparib The metabolism of Amiodarone can be decreased when combined with Olaparib.
Methamphetamine	Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Amiodarone.
Tasimelteon	Tasimelteon The metabolism of Amiodarone can be decreased when combined with Tasimelteon.
Riociguat	Riociguat The metabolism of Amiodarone can be decreased when combined with Riociguat.
Lanreotide Injection	Lanreotide Injection The metabolism of Amiodarone can be decreased when combined with Lanreotide.
Pirfenidone	Pirfenidone The metabolism of Amiodarone can be decreased when combined with Pirfenidone.
Nintedanib	Nintedanib The metabolism of Amiodarone can be decreased when combined with Nintedanib.
Secukinumab Injection	Secukinumab Injection The metabolism of Amiodarone can be increased when combined with Secukinumab.
Risperidone Injection	Risperidone Injection Amiodarone may increase the hypotensive activities of Risperidone.
Palbociclib	Palbociclib The metabolism of Amiodarone can be decreased when combined with Palbociclib.
Insulin Human Inhalation	Insulin Human Inhalation The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin human.
Lenvatinib	Lenvatinib The metabolism of Lenvatinib can be increased when combined with Amiodarone.
Naloxegol	Naloxegol The serum concentration of Naloxegol can be increased when it is combined with Amiodarone.
Panobinostat	Panobinostat The serum concentration of Panobinostat can be increased when it is combined with Amiodarone.
Dinutuximab Injection	Dinutuximab Injection The risk or severity of adverse effects can be increased when Amiodarone is combined with Dinutuximab.
Haloperidol Injection	Haloperidol Injection The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Amiodarone.
Ivabradine	Ivabradine Ivabradine may increase the bradycardic activities of Amiodarone.
Amiloride	Amiloride The risk or severity of hyperkalemia can be increased when Amiloride is combined with Amiodarone.
Isavuconazonium Injection	Isavuconazonium Injection The metabolism of Amiodarone can be increased when combined with Isavuconazonium.
Macitentan	Macitentan Amiodarone may increase the hypotensive activities of Macitentan.
Sonidegib	Sonidegib The metabolism of Sonidegib can be decreased when combined with Amiodarone.
Prednisolone	Prednisolone The metabolism of Amiodarone can be increased when combined with Prednisolone.
Daclatasvir	Daclatasvir Daclatasvir may increase the bradycardic activities of Amiodarone.
Brexpiprazole	Brexpiprazole The risk or severity of hypotension can be increased when Amiodarone is combined with Brexpiprazole.
Ziprasidone Injection	Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Amiodarone.
Cariprazine	Cariprazine The metabolism of Cariprazine can be decreased when combined with Amiodarone.
Insulin Degludec (rDNA Origin) Injection	Insulin Degludec (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin degludec.
Cobimetinib	Cobimetinib The serum concentration of Amiodarone can be increased when it is combined with Cobimetinib.
Trabectedin Injection	Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Amiodarone.
Osimertinib	Osimertinib The metabolism of Osimertinib can be increased when combined with Amiodarone.
Alectinib	Alectinib The metabolism of Alectinib can be decreased when combined with Amiodarone.
Ixazomib	Ixazomib The metabolism of Ixazomib can be decreased when combined with Amiodarone.
Rifapentine	Rifapentine The metabolism of Amiodarone can be increased when combined with Rifapentine.
Lesinurad	Lesinurad The metabolism of Lesinurad can be increased when combined with Amiodarone.
Amphotericin B Liposomal Injection	Amphotericin B Liposomal Injection Amiodarone may decrease the nephrotoxic activities of Amphotericin B.
Dexamethasone Injection	Dexamethasone Injection The metabolism of Amiodarone can be decreased when combined with Dexamethasone.
Brivaracetam Injection	Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Amiodarone.
Venetoclax	Venetoclax The metabolism of Amiodarone can be decreased when combined with Venetoclax.
Cobicistat	Cobicistat The metabolism of Amiodarone can be decreased when combined with Cobicistat.
Midodrine	Midodrine Midodrine may increase the bradycardic activities of Amiodarone.
Selexipag	Selexipag The metabolism of Amiodarone can be decreased when combined with Selexipag.
Diphenhydramine Injection	Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Amiodarone.
Furosemide Injection	Furosemide Injection The risk or severity of adverse effects can be increased when Furosemide is combined with Amiodarone.
Rucaparib	Rucaparib The metabolism of Rucaparib can be decreased when combined with Amiodarone.
Lixisenatide Injection	Lixisenatide Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Lixisenatide.
Ribociclib	Ribociclib The metabolism of Amiodarone can be decreased when combined with Ribociclib.
Brigatinib	Brigatinib The metabolism of Amiodarone can be increased when combined with Brigatinib.
Doxepin (Insomnia)	Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Amiodarone.
Plecanatide	Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Amiodarone.
Deutetrabenazine	Deutetrabenazine The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Deutetrabenazine.
Valbenazine	Valbenazine The metabolism of Valbenazine can be decreased when combined with Amiodarone.
Deflazacort	Deflazacort The metabolism of Amiodarone can be increased when combined with Deflazacort.
Safinamide	Safinamide Safinamide may increase the orthostatic hypotensive activities of Amiodarone.
Sarilumab Injection	Sarilumab Injection The metabolism of Amiodarone can be increased when combined with Sarilumab.
Midostaurin	Midostaurin The metabolism of Amiodarone can be increased when combined with Midostaurin.
Neratinib	Neratinib The metabolism of Neratinib can be decreased when combined with Amiodarone.
Enasidenib	Enasidenib The metabolism of Amiodarone can be increased when combined with Enasidenib.
Inotuzumab Ozogamicin Injection	Inotuzumab Ozogamicin Injection The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Amiodarone.
Aprepitant/Fosaprepitant Injection	Aprepitant/Fosaprepitant Injection The metabolism of Amiodarone can be increased when combined with Fosaprepitant.
Copanlisib Injection	Copanlisib Injection The serum concentration of Amiodarone can be increased when it is combined with Copanlisib.
Delafloxacin	Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Amiodarone.
Abemaciclib	Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Amiodarone.
Betrixaban	Betrixaban The serum concentration of Betrixaban can be increased when it is combined with Amiodarone.
Acalabrutinib	Acalabrutinib The metabolism of Amiodarone can be decreased when combined with Acalabrutinib.
Letermovir	Letermovir The metabolism of Amiodarone can be decreased when combined with Letermovir.
Semaglutide Injection	Semaglutide Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Semaglutide.
Tetrabenazine	Tetrabenazine The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Tetrabenazine.
Ertugliflozin	Ertugliflozin The serum concentration of Ertugliflozin can be increased when it is combined with Amiodarone.
Buprenorphine Injection	Buprenorphine Injection The metabolism of Amiodarone can be decreased when combined with Buprenorphine.
Apalutamide	Apalutamide The metabolism of Amiodarone can be increased when combined with Apalutamide.
Penicillamine	Penicillamine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Amiodarone.
Fostamatinib	Fostamatinib The metabolism of Amiodarone can be decreased when combined with Fostamatinib.
Avatrombopag	Avatrombopag The metabolism of Amiodarone can be increased when combined with Avatrombopag.
Baricitinib	Baricitinib The metabolism of Amiodarone can be decreased when combined with Baricitinib.
Lofexidine	Lofexidine The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Lofexidine.
Eliglustat	Eliglustat The metabolism of Eliglustat can be decreased when combined with Amiodarone.
Encorafenib	Encorafenib The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Encorafenib.
Binimetinib	Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Amiodarone.
Ivosidenib	Ivosidenib The metabolism of Amiodarone can be increased when combined with Ivosidenib.
Lusutrombopag	Lusutrombopag The serum concentration of Lusutrombopag can be increased when it is combined with Amiodarone.
Elagolix	Elagolix The metabolism of Amiodarone can be decreased when combined with Elagolix.
Tafenoquine	Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Amiodarone.
Cannabidiol	Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Amiodarone.
Dacomitinib	Dacomitinib The serum concentration of Dacomitinib can be increased when it is combined with Amiodarone.
Duvelisib	Duvelisib The metabolism of Amiodarone can be decreased when combined with Duvelisib.
Omadacycline	Omadacycline The serum concentration of Omadacycline can be increased when it is combined with Amiodarone.
Stiripentol	Stiripentol The metabolism of Amiodarone can be decreased when combined with Stiripentol.
Talazoparib	Talazoparib The serum concentration of Talazoparib can be increased when it is combined with Amiodarone.
Gilteritinib	Gilteritinib The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Amiodarone.
Glasdegib	Glasdegib The metabolism of Amiodarone can be decreased when combined with Glasdegib.
Lorlatinib	Lorlatinib The metabolism of Amiodarone can be decreased when combined with Lorlatinib.
Larotrectinib	Larotrectinib The serum concentration of Amiodarone can be increased when it is combined with Larotrectinib.
Paclitaxel (with albumin) Injection	Paclitaxel (with albumin) Injection The metabolism of Amiodarone can be increased when combined with Paclitaxel.
Rifamycin	Rifamycin The metabolism of Amiodarone can be increased when combined with Rifamycin.
Prucalopride	Prucalopride The serum concentration of Prucalopride can be increased when it is combined with Amiodarone.
Magnesium Citrate	Magnesium Citrate The risk or severity of hypotension can be increased when Amiodarone is combined with Magnesium citrate.
Emapalumab-lzsg Injection	Emapalumab-lzsg Injection The metabolism of Amiodarone can be increased when combined with Emapalumab.
Siponimod	Siponimod The risk or severity of adverse effects can be increased when Amiodarone is combined with Siponimod.
Acyclovir Ophthalmic	Acyclovir Ophthalmic The metabolism of Acyclovir can be decreased when combined with Amiodarone.
Erdafitinib	Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Amiodarone.
Alpelisib	Alpelisib The metabolism of Amiodarone can be increased when combined with Alpelisib.
Cladribine	Cladribine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Amiodarone.
Solriamfetol	Solriamfetol The serum concentration of Solriamfetol can be increased when it is combined with Amiodarone.
Darolutamide	Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Amiodarone.
Triclabendazole	Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Amiodarone.
Entrectinib	Entrectinib The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Entrectinib.
Pexidartinib	Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Amiodarone.
Istradefylline	Istradefylline The metabolism of Istradefylline can be decreased when combined with Amiodarone.
Pitolisant	Pitolisant The serum concentration of Amiodarone can be decreased when it is combined with Pitolisant.
Fedratinib	Fedratinib The serum concentration of Fedratinib can be increased when it is combined with Amiodarone.
Lefamulin	Lefamulin Amiodarone may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection	Phenytoin Injection The serum concentration of Amiodarone can be decreased when it is combined with Phenytoin.
Fosphenytoin Injection	Fosphenytoin Injection The serum concentration of Amiodarone can be decreased when it is combined with Fosphenytoin.
Enfortumab vedotin-ejfv Injection	Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be increased when it is combined with Amiodarone.
Zanubrutinib	Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Amiodarone.
Voxelotor	Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Amiodarone.
Avapritinib	Avapritinib The metabolism of Avapritinib can be decreased when combined with Amiodarone.
Lasmiditan	Lasmiditan Lasmiditan may increase the bradycardic activities of Amiodarone.
Ubrogepant	Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Amiodarone.
Calcium Acetate	Calcium Acetate The therapeutic efficacy of Amiodarone can be decreased when used in combination with Calcium acetate.
Tazemetostat	Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Amiodarone.
Cenobamate	Cenobamate The serum concentration of Cenobamate can be decreased when it is combined with Amiodarone.
Ozanimod	Ozanimod The metabolism of Ozanimod can be decreased when combined with Amiodarone.
Selumetinib	Selumetinib The metabolism of Selumetinib can be decreased when combined with Amiodarone.
Rimegepant	Rimegepant The serum concentration of Rimegepant can be increased when it is combined with Amiodarone.
Tucatinib	Tucatinib The metabolism of Tucatinib can be decreased when combined with Amiodarone.
Remdesivir Injection	Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Amiodarone.
Ripretinib	Ripretinib The serum concentration of Ripretinib can be increased when it is combined with Amiodarone.
Selpercatinib	Selpercatinib The serum concentration of Amiodarone can be increased when it is combined with Selpercatinib.
Capmatinib	Capmatinib The serum concentration of Capmatinib can be increased when it is combined with Amiodarone.
Lemborexant	Lemborexant The serum concentration of Lemborexant can be increased when it is combined with Amiodarone.
Fostemsavir	Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Amiodarone.
Octreotide	Octreotide The serum concentration of the active metabolites of Amiodarone can be increased when Amiodarone is used in combination with Octreotide.
Belantamab Mafodotin-blmf Injection	Belantamab Mafodotin-blmf Injection The serum concentration of Belantamab mafodotin can be increased when it is combined with Amiodarone.
Pralsetinib	Pralsetinib The serum concentration of Pralsetinib can be increased when it is combined with Amiodarone.
Opicapone	Opicapone The metabolism of Amiodarone can be decreased when combined with Opicapone.
Satralizumab-mwge Injection	Satralizumab-mwge Injection The serum concentration of Amiodarone can be decreased when it is combined with Satralizumab.
Relugolix	Relugolix The serum concentration of Relugolix can be increased when it is combined with Amiodarone.
Progestin-Only (drospirenone) Oral Contraceptives	Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Amiodarone can be decreased when combined with Drospirenone.
Vitamin E (Alpha-Tocopherol)	Vitamin E (Alpha-Tocopherol) The metabolism of Vitamin E can be increased when combined with Amiodarone.
Theophylline	Theophylline The metabolism of Amiodarone can be decreased when combined with Theophylline.
Fenoprofen	Fenoprofen The risk or severity of hyperkalemia can be increased when Fenoprofen is combined with Amiodarone.
Indomethacin	Indomethacin The metabolism of Amiodarone can be decreased when combined with Indomethacin.
Mefenamic Acid	Mefenamic Acid The metabolism of Amiodarone can be decreased when combined with Mefenamic acid.
Naproxen	Naproxen The metabolism of Amiodarone can be decreased when combined with Naproxen.
Tolmetin	Tolmetin The risk or severity of hyperkalemia can be increased when Tolmetin is combined with Amiodarone.
Sulindac	Sulindac The risk or severity of hyperkalemia can be increased when Sulindac is combined with Amiodarone.
Trazodone	Trazodone Trazodone may increase the QTc-prolonging activities of Amiodarone.
Isotretinoin	Isotretinoin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Amiodarone.
Phenobarbital	Phenobarbital The metabolism of Phenobarbital can be increased when combined with Amiodarone.
Methotrexate Injection	Methotrexate Injection The metabolism of Amiodarone can be decreased when combined with Methotrexate.
Primidone	Primidone The metabolism of Amiodarone can be increased when combined with Primidone.
Methsuximide	Methsuximide The risk or severity of adverse effects can be increased when Methsuximide is combined with Amiodarone.
Chlorpromazine	Chlorpromazine The metabolism of Amiodarone can be increased when combined with Chlorpromazine.
Diazepam	Diazepam The metabolism of Amiodarone can be decreased when combined with Diazepam.
Flurazepam	Flurazepam The metabolism of Flurazepam can be decreased when combined with Amiodarone.
Lorazepam	Lorazepam The metabolism of Amiodarone can be decreased when combined with Lorazepam.
Phenoxybenzamine	Phenoxybenzamine The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Amiodarone.
Carmustine	Carmustine The metabolism of Carmustine can be decreased when combined with Amiodarone.
Amantadine	Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Amiodarone.
Codeine	Codeine The metabolism of Codeine can be decreased when combined with Amiodarone.
Bromocriptine	Bromocriptine The metabolism of Bromocriptine can be decreased when combined with Amiodarone.
Tranylcypromine	Tranylcypromine The metabolism of Amiodarone can be decreased when combined with Tranylcypromine.
Phenelzine	Phenelzine The metabolism of Amiodarone can be decreased when combined with Phenelzine.
Procarbazine	Procarbazine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Procarbazine.
Tetracycline	Tetracycline The metabolism of Amiodarone can be decreased when combined with Tetracycline.
Minocycline	Minocycline The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Amiodarone.
Prochlorperazine	Prochlorperazine The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Prochlorperazine.
Thioridazine	Thioridazine The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Thioridazine.
Trifluoperazine	Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Amiodarone.
Dapsone	Dapsone The metabolism of Amiodarone can be decreased when combined with Dapsone.
Sulfadiazine	Sulfadiazine The metabolism of Amiodarone can be decreased when combined with Sulfadiazine.
Oxycodone	Oxycodone The metabolism of Oxycodone can be decreased when combined with Amiodarone.
Methadone	Methadone The metabolism of Methadone can be increased when combined with Amiodarone.
Oxybutynin	Oxybutynin The metabolism of Amiodarone can be decreased when combined with Oxybutynin.
Benztropine	Benztropine The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Benzatropine.
Colestipol	Colestipol The excretion of Amiodarone can be increased when combined with Colestipol.
Maprotiline	Maprotiline The metabolism of Maprotiline can be decreased when combined with Amiodarone.
Ibuprofen	Ibuprofen The metabolism of Amiodarone can be decreased when combined with Ibuprofen.
Orphenadrine	Orphenadrine The metabolism of Amiodarone can be decreased when combined with Orphenadrine.
Perphenazine	Perphenazine The metabolism of Perphenazine can be decreased when combined with Amiodarone.
Azathioprine	Azathioprine The metabolism of Azathioprine can be decreased when combined with Amiodarone.
Phentermine	Phentermine The metabolism of Amiodarone can be decreased when combined with Phentermine.
Amoxapine	Amoxapine The metabolism of Amoxapine can be decreased when combined with Amiodarone.
Sulfasalazine	Sulfasalazine The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Amiodarone.
Hydrocortisone	Hydrocortisone The metabolism of Amiodarone can be increased when combined with Hydrocortisone.
Doxorubicin	Doxorubicin The serum concentration of Doxorubicin can be increased when it is combined with Amiodarone.
Cytarabine	Cytarabine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cytarabine is combined with Amiodarone.
Dactinomycin	Dactinomycin The serum concentration of Dactinomycin can be increased when it is combined with Amiodarone.
Carbamazepine	Carbamazepine The metabolism of Amiodarone can be increased when combined with Carbamazepine.
Methyldopa	Methyldopa The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methyldopa is combined with Amiodarone.
Clonidine	Clonidine Clonidine may increase the atrioventricular blocking (AV block) activities of Amiodarone.
Prazosin	Prazosin The serum concentration of Prazosin can be increased when it is combined with Amiodarone.
Hydralazine	Hydralazine The metabolism of Amiodarone can be decreased when combined with Hydralazine.
Cimetidine	Cimetidine The serum concentration of Amiodarone can be increased when it is combined with Cimetidine.
Warfarin	Warfarin The risk or severity of bleeding can be increased when Amiodarone is combined with Warfarin.
Loperamide	Loperamide The risk or severity of adverse effects can be increased when Loperamide is combined with Amiodarone.
Promethazine	Promethazine The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Promethazine.
Meclofenamate	Meclofenamate The risk or severity of hyperkalemia can be increased when Meclofenamic acid is combined with Amiodarone.
Daunorubicin	Daunorubicin The metabolism of Amiodarone can be decreased when combined with Daunorubicin.
Nitrofurantoin	Nitrofurantoin The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Amiodarone.
Griseofulvin	Griseofulvin The metabolism of Amiodarone can be increased when combined with Griseofulvin.
Digoxin	Digoxin The serum concentration of Digoxin can be increased when it is combined with Amiodarone.
Chloroquine	Chloroquine The metabolism of Amiodarone can be decreased when combined with Chloroquine.
Quinine	Quinine The metabolism of Quinine can be increased when combined with Amiodarone.
Ethosuximide	Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Amiodarone.
Calcitriol	Calcitriol The metabolism of Amiodarone can be increased when combined with Calcitriol.
Triamterene	Triamterene The metabolism of Triamterene can be decreased when combined with Amiodarone.
Lactulose	Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Amiodarone.
Sulfinpyrazone	Sulfinpyrazone The metabolism of Amiodarone can be increased when combined with Sulfinpyrazone.
Chlorothiazide	Chlorothiazide The risk or severity of adverse effects can be increased when Amiodarone is combined with Chlorothiazide.
Chlorthalidone	Chlorthalidone The risk or severity of adverse effects can be increased when Amiodarone is combined with Chlorthalidone.
Metolazone	Metolazone The risk or severity of adverse effects can be increased when Amiodarone is combined with Metolazone.
Isosorbide	Isosorbide Amiodarone may increase the vasodilatory activities of Isosorbide.
Clindamycin Injection	Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Amiodarone.
Secobarbital	Secobarbital The metabolism of Amiodarone can be increased when combined with Secobarbital.
Desipramine	Desipramine The metabolism of Desipramine can be decreased when combined with Amiodarone.
Amitriptyline	Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Amiodarone.
Imipramine	Imipramine The serum concentration of Imipramine can be increased when it is combined with Amiodarone.
Probenecid	Probenecid The metabolism of Amiodarone can be increased when combined with Probenecid.
Quinidine	Quinidine The serum concentration of Quinidine can be increased when it is combined with Amiodarone.
Procainamide	Procainamide The serum concentration of Procainamide can be increased when it is combined with Amiodarone.
Isoniazid	Isoniazid The metabolism of Amiodarone can be decreased when combined with Isoniazid.
Rifampin	Rifampin The serum concentration of Amiodarone can be decreased when it is combined with Rifampicin.
Disopyramide	Disopyramide Amiodarone may increase the QTc-prolonging activities of Disopyramide.
Valproic Acid	Valproic Acid The metabolism of Amiodarone can be decreased when combined with Valproic acid.
Tamoxifen	Tamoxifen The metabolism of Amiodarone can be increased when combined with Tamoxifen.
Butabarbital	Butabarbital Butabarbital may increase the hypotensive activities of Amiodarone.
Levothyroxine	Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Amiodarone.
Liothyronine	Liothyronine The therapeutic efficacy of Liothyronine can be decreased when used in combination with Amiodarone.
Methimazole	Methimazole The therapeutic efficacy of Methimazole can be decreased when used in combination with Amiodarone.
Propylthiouracil	Propylthiouracil The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Amiodarone.
Chlorpropamide	Chlorpropamide The metabolism of Chlorpropamide can be decreased when combined with Amiodarone.
Tolbutamide	Tolbutamide The metabolism of Amiodarone can be decreased when combined with Tolbutamide.
Tolazamide	Tolazamide The metabolism of Tolazamide can be decreased when combined with Amiodarone.
Dextromethorphan	Dextromethorphan The serum concentration of Amiodarone can be increased when it is combined with Dextromethorphan.
Cyclobenzaprine	Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Amiodarone.
Niacin	Niacin The metabolism of Amiodarone can be decreased when combined with Niacin.
Baclofen	Baclofen The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Amiodarone.
Doxylamine	Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Amiodarone.
Cyproheptadine	Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Amiodarone.
Clemastine	Clemastine The risk or severity of QTc prolongation can be increased when Clemastine is combined with Amiodarone.
Chlorpheniramine	Chlorpheniramine The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Chlorpheniramine.
Brompheniramine	Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Amiodarone.
Meclizine	Meclizine The metabolism of Meclizine can be decreased when combined with Amiodarone.
Methyclothiazide	Methyclothiazide The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Amiodarone.
Hydrochlorothiazide	Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Amiodarone.
Dantrolene	Dantrolene The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Amiodarone.
Chlorzoxazone	Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Amiodarone.
Danazol	Danazol The metabolism of Amiodarone can be decreased when combined with Danazol.
Disulfiram	Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Amiodarone.
Propranolol (Cardiovascular)	Propranolol (Cardiovascular) The therapeutic efficacy of Propranolol can be increased when used in combination with Amiodarone.
Minoxidil	Minoxidil The risk or severity of adverse effects can be increased when Amiodarone is combined with Minoxidil.
Nortriptyline	Nortriptyline The serum concentration of Nortriptyline can be increased when it is combined with Amiodarone.
Spironolactone	Spironolactone The metabolism of Amiodarone can be decreased when combined with Spironolactone.
Amphotericin B Injection	Amphotericin B Injection Amiodarone may decrease the nephrotoxic activities of Amphotericin B.
Nadolol	Nadolol The therapeutic efficacy of Nadolol can be increased when used in combination with Amiodarone.
Cholestyramine Resin	Cholestyramine Resin The serum concentration of Amiodarone can be decreased when it is combined with Cholestyramine.
Oxytocin Injection	Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Amiodarone.
Clomiphene	Clomiphene The serum concentration of Amiodarone can be increased when it is combined with Clomifene.
Papaverine	Papaverine The risk or severity of QTc prolongation can be increased when Papaverine is combined with Amiodarone.
Fluorouracil Injection	Fluorouracil Injection The metabolism of Amiodarone can be decreased when combined with Fluorouracil.
Colchicine	Colchicine The metabolism of Colchicine can be decreased when combined with Amiodarone.
Cephalexin	Cephalexin The metabolism of Amiodarone can be decreased when combined with Cephalexin.
Dacarbazine	Dacarbazine The metabolism of Dacarbazine can be decreased when combined with Amiodarone.
Acetazolamide	Acetazolamide The metabolism of Amiodarone can be decreased when combined with Acetazolamide.
Ketoconazole	Ketoconazole The metabolism of Amiodarone can be decreased when combined with Ketoconazole.
Thiotepa Injection	Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Amiodarone.
Vincristine Injection	Vincristine Injection The excretion of Vincristine can be decreased when combined with Amiodarone.
Captopril	Captopril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Captopril.
Dipyridamole	Dipyridamole The risk or severity of adverse effects can be increased when Dipyridamole is combined with Amiodarone.
Isoxsuprine	Isoxsuprine The risk or severity of adverse effects can be increased when Amiodarone is combined with Isoxsuprine.
Vinblastine	Vinblastine The metabolism of Amiodarone can be decreased when combined with Vinblastine.
Ethacrynic Acid	Ethacrynic Acid The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Amiodarone.
Metoprolol	Metoprolol The therapeutic efficacy of Metoprolol can be increased when used in combination with Amiodarone.
Hydroxyzine	Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Amiodarone.
Thiothixene	Thiothixene The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Thiothixene.
Aspirin	Aspirin The metabolism of Amiodarone can be decreased when combined with Acetylsalicylic acid.
Salsalate	Salsalate The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Salsalate.
Alprazolam	Alprazolam The metabolism of Alprazolam can be decreased when combined with Amiodarone.
Triazolam	Triazolam The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Amiodarone.
Hyoscyamine	Hyoscyamine The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Amiodarone.
Trimethoprim	Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Amiodarone.
Diltiazem	Diltiazem The risk or severity of adverse effects can be increased when Diltiazem is combined with Amiodarone.
Nifedipine	Nifedipine The risk or severity of adverse effects can be increased when Amiodarone is combined with Nifedipine.
Timolol	Timolol The therapeutic efficacy of Timolol can be increased when used in combination with Amiodarone.
Verapamil	Verapamil The risk or severity of adverse effects can be increased when Verapamil is combined with Amiodarone.
Atenolol	Atenolol The therapeutic efficacy of Atenolol can be increased when used in combination with Amiodarone.
Pindolol	Pindolol The therapeutic efficacy of Pindolol can be increased when used in combination with Amiodarone.
Cisplatin Injection	Cisplatin Injection The serum concentration of Cisplatin can be increased when it is combined with Amiodarone.
Diflunisal	Diflunisal The risk or severity of hyperkalemia can be increased when Diflunisal is combined with Amiodarone.
Piroxicam	Piroxicam The metabolism of Amiodarone can be decreased when combined with Piroxicam.
Bumetanide	Bumetanide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Amiodarone.
Etoposide	Etoposide The metabolism of Amiodarone can be increased when combined with Etoposide.
Glyburide	Glyburide The metabolism of Amiodarone can be decreased when combined with Glyburide.
Glipizide	Glipizide The metabolism of Glipizide can be decreased when combined with Amiodarone.
Indapamide	Indapamide The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Indapamide.
Dicloxacillin	Dicloxacillin The metabolism of Amiodarone can be increased when combined with Dicloxacillin.
Nafcillin Injection	Nafcillin Injection The therapeutic efficacy of Amiodarone can be decreased when used in combination with Nafcillin.
Pentoxifylline	Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Amiodarone.
Pentamidine Injection	Pentamidine Injection The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Pentamidine.
Labetalol	Labetalol The therapeutic efficacy of Labetalol can be increased when used in combination with Amiodarone.
Leuprolide Injection	Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Amiodarone.
Gemfibrozil	Gemfibrozil The metabolism of Amiodarone can be decreased when combined with Gemfibrozil.
Guanabenz	Guanabenz The metabolism of Guanabenz can be decreased when combined with Amiodarone.
Ketoprofen	Ketoprofen The metabolism of Amiodarone can be decreased when combined with Ketoprofen.
Pimozide	Pimozide The metabolism of Amiodarone can be decreased when combined with Pimozide.
Enalapril	Enalapril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Enalapril.
Flurbiprofen	Flurbiprofen The metabolism of Flurbiprofen can be decreased when combined with Amiodarone.
Buspirone	Buspirone The metabolism of Buspirone can be decreased when combined with Amiodarone.
Lovastatin	Lovastatin The serum concentration of Lovastatin can be increased when it is combined with Amiodarone.
Ciprofloxacin	Ciprofloxacin The metabolism of Ciprofloxacin can be decreased when combined with Amiodarone.
Mesalamine	Mesalamine The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Amiodarone.
Diclofenac	Diclofenac The metabolism of Amiodarone can be decreased when combined with Diclofenac.
Fluoxetine	Fluoxetine The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Fluoxetine.
Nimodipine	Nimodipine The risk or severity of adverse effects can be increased when Amiodarone is combined with Nimodipine.
Clozapine	Clozapine The metabolism of Clozapine can be increased when combined with Amiodarone.
Idarubicin	Idarubicin The metabolism of Idarubicin can be decreased when combined with Amiodarone.
Ofloxacin	Ofloxacin The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Amiodarone.
Clarithromycin	Clarithromycin The metabolism of Amiodarone can be decreased when combined with Clarithromycin.
Benazepril	Benazepril The risk or severity of hyperkalemia can be increased when Benazepril is combined with Amiodarone.
Etodolac	Etodolac The metabolism of Etodolac can be decreased when combined with Amiodarone.
Felodipine	Felodipine The risk or severity of adverse effects can be increased when Felodipine is combined with Amiodarone.
Fosinopril	Fosinopril The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Amiodarone.
Nabumetone	Nabumetone The metabolism of Nabumetone can be decreased when combined with Amiodarone.
Pravastatin	Pravastatin The metabolism of Pravastatin can be increased when combined with Amiodarone.
Quinapril	Quinapril The risk or severity of hyperkalemia can be increased when Quinapril is combined with Amiodarone.
Ramipril	Ramipril The risk or severity of hyperkalemia can be increased when Ramipril is combined with Amiodarone.
Simvastatin	Simvastatin The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.
Amlodipine	Amlodipine The risk or severity of adverse effects can be increased when Amlodipine is combined with Amiodarone.
Teniposide Injection	Teniposide Injection The metabolism of Amiodarone can be decreased when combined with Teniposide.
Itraconazole	Itraconazole The metabolism of Amiodarone can be decreased when combined with Itraconazole.
Lisinopril	Lisinopril The risk or severity of hyperkalemia can be increased when Lisinopril is combined with Amiodarone.
Oxaprozin	Oxaprozin The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Amiodarone.
Rifabutin	Rifabutin The metabolism of Amiodarone can be increased when combined with Rifabutin.
Sotalol	Sotalol The therapeutic efficacy of Sotalol can be increased when used in combination with Amiodarone.
Bisoprolol	Bisoprolol The therapeutic efficacy of Amiodarone can be increased when used in combination with Bisoprolol.
Zolpidem	Zolpidem The metabolism of Zolpidem can be decreased when combined with Amiodarone.
Doxazosin	Doxazosin The metabolism of Doxazosin can be decreased when combined with Amiodarone.
Terazosin	Terazosin The risk or severity of hypotension can be increased when Terazosin is combined with Amiodarone.
Isradipine	Isradipine The risk or severity of adverse effects can be increased when Isradipine is combined with Amiodarone.
Omeprazole	Omeprazole The metabolism of Amiodarone can be increased when combined with Omeprazole.
Cisapride	Cisapride The metabolism of Amiodarone can be decreased when combined with Cisapride.
Fluvastatin	Fluvastatin The metabolism of Fluvastatin can be increased when combined with Amiodarone.
Venlafaxine	Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Amiodarone.
Nizatidine	Nizatidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Amiodarone.
Stavudine	Stavudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Amiodarone.
Famciclovir	Famciclovir The metabolism of Amiodarone can be decreased when combined with Famciclovir.
Fluvoxamine	Fluvoxamine The metabolism of Amiodarone can be decreased when combined with Fluvoxamine.
Nefazodone	Nefazodone The metabolism of Amiodarone can be decreased when combined with Nefazodone.
Lamotrigine	Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Amiodarone.
Losartan	Losartan The risk or severity of adverse effects can be increased when Losartan is combined with Amiodarone.
Tramadol	Tramadol The metabolism of Amiodarone can be decreased when combined with Tramadol.
Vinorelbine Injection	Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Amiodarone.
Moexipril	Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Amiodarone.
Lansoprazole	Lansoprazole The metabolism of Amiodarone can be increased when combined with Lansoprazole.
Ifosfamide Injection	Ifosfamide Injection The metabolism of Amiodarone can be increased when combined with Ifosfamide.
Nicardipine	Nicardipine The risk or severity of adverse effects can be increased when Nicardipine is combined with Amiodarone.
Bupropion	Bupropion The metabolism of Bupropion can be decreased when combined with Amiodarone.
Ticlopidine	Ticlopidine The metabolism of Amiodarone can be decreased when combined with Ticlopidine.
Saquinavir	Saquinavir The serum concentration of Saquinavir can be increased when it is combined with Amiodarone.
Metformin	Metformin The serum concentration of Metformin can be increased when it is combined with Amiodarone.
Dalteparin Injection	Dalteparin Injection The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Dalteparin.
Nisoldipine	Nisoldipine The risk or severity of adverse effects can be increased when Nisoldipine is combined with Amiodarone.
Lamivudine	Lamivudine The serum concentration of Lamivudine can be increased when it is combined with Amiodarone.
Riluzole	Riluzole The metabolism of Riluzole can be decreased when combined with Amiodarone.
Amifostine Injection	Amifostine Injection The risk or severity of adverse effects can be increased when Amiodarone is combined with Amifostine.
Acarbose	Acarbose The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Acarbose.
Glimepiride	Glimepiride The risk or severity of adverse effects can be increased when Glimepiride is combined with Amiodarone.
Anastrozole	Anastrozole The metabolism of Amiodarone can be decreased when combined with Anastrozole.
Gemcitabine Injection	Gemcitabine Injection The serum concentration of Gemcitabine can be increased when it is combined with Amiodarone.
Indinavir	Indinavir The serum concentration of Amiodarone can be increased when it is combined with Indinavir.
Ritonavir	Ritonavir The metabolism of Amiodarone can be decreased when combined with Ritonavir.
Docetaxel Injection	Docetaxel Injection The metabolism of Amiodarone can be decreased when combined with Docetaxel.
Clomipramine	Clomipramine The metabolism of Clomipramine can be decreased when combined with Amiodarone.
Zafirlukast	Zafirlukast The metabolism of Amiodarone can be decreased when combined with Zafirlukast.
Mirtazapine	Mirtazapine The metabolism of Amiodarone can be decreased when combined with Mirtazapine.
Trandolapril	Trandolapril The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Amiodarone.
Topiramate	Topiramate The metabolism of Amiodarone can be increased when combined with Topiramate.
Zileuton	Zileuton The metabolism of Zileuton can be decreased when combined with Amiodarone.
Valsartan	Valsartan The metabolism of Valsartan can be decreased when combined with Amiodarone.
Insulin Lispro Injection	Insulin Lispro Injection The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin lispro.
Pramipexole	Pramipexole The serum concentration of Amiodarone can be increased when it is combined with Pramipexole.
Donepezil	Donepezil The metabolism of Donepezil can be decreased when combined with Amiodarone.
Nelfinavir	Nelfinavir The serum concentration of Nelfinavir can be increased when it is combined with Amiodarone.
Fexofenadine	Fexofenadine The serum concentration of Amiodarone can be increased when it is combined with Fexofenadine.
Azithromycin	Azithromycin The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Amiodarone.
Loratadine	Loratadine The risk or severity of QTc prolongation can be increased when Loratadine is combined with Amiodarone.
Carvedilol	Carvedilol The therapeutic efficacy of Carvedilol can be increased when used in combination with Amiodarone.
Nilutamide	Nilutamide The metabolism of Amiodarone can be decreased when combined with Nilutamide.
Flutamide	Flutamide The metabolism of Flutamide can be decreased when combined with Amiodarone.
Selegiline	Selegiline The metabolism of Amiodarone can be decreased when combined with Selegiline.
Bicalutamide	Bicalutamide The metabolism of Amiodarone can be decreased when combined with Bicalutamide.
Sertraline	Sertraline The metabolism of Sertraline can be decreased when combined with Amiodarone.
Propafenone	Propafenone The risk or severity of adverse effects can be increased when Amiodarone is combined with Propafenone.
Letrozole	Letrozole The metabolism of Letrozole can be decreased when combined with Amiodarone.
Raloxifene	Raloxifene The metabolism of Amiodarone can be decreased when combined with Raloxifene.
Irbesartan	Irbesartan The metabolism of Amiodarone can be decreased when combined with Irbesartan.
Tamsulosin	Tamsulosin The risk or severity of hypotension can be increased when Amiodarone is combined with Tamsulosin.
Ropinirole	Ropinirole The risk or severity of adverse effects can be increased when Amiodarone is combined with Ropinirole.
Quetiapine	Quetiapine The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Quetiapine.
Cetirizine	Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Amiodarone.
Paroxetine	Paroxetine The metabolism of Amiodarone can be decreased when combined with Paroxetine.
Tolcapone	Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Amiodarone.
Citalopram	Citalopram The metabolism of Amiodarone can be decreased when combined with Citalopram.
Capecitabine	Capecitabine The metabolism of Capecitabine can be decreased when combined with Amiodarone.
Efavirenz	Efavirenz The serum concentration of Amiodarone can be decreased when it is combined with Efavirenz.
Sildenafil	Sildenafil The metabolism of Sildenafil can be decreased when combined with Amiodarone.
Pioglitazone	Pioglitazone The metabolism of Amiodarone can be decreased when combined with Pioglitazone.
Celecoxib	Celecoxib The metabolism of Celecoxib can be decreased when combined with Amiodarone.
Rosiglitazone	Rosiglitazone The metabolism of Amiodarone can be decreased when combined with Rosiglitazone.
Tolterodine	Tolterodine The metabolism of Tolterodine can be decreased when combined with Amiodarone.
Thalidomide	Thalidomide The metabolism of Amiodarone can be decreased when combined with Thalidomide.
Colesevelam	Colesevelam The excretion of Amiodarone can be increased when combined with Colesevelam.
Balsalazide	Balsalazide The risk or severity of hyperkalemia can be increased when Balsalazide is combined with Amiodarone.
Nateglinide	Nateglinide The metabolism of Nateglinide can be decreased when combined with Amiodarone.
Galantamine	Galantamine The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Galantamine.
Rabeprazole	Rabeprazole The metabolism of Amiodarone can be decreased when combined with Rabeprazole.
Terbinafine	Terbinafine The metabolism of Terbinafine can be increased when combined with Amiodarone.